Singhal Priya's Form 4 filing
Biogen Inc. (BIIB) · filed Feb 10, 2026
- Accession no.
- 0000875045-26-000023
- Filed
- Feb 10, 2026
- Trade date
- Feb 6-9, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $531.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Singhal PriyaCIK 0001769608 | Officer (Head of Development) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 6, 2026 | Common Stock | MOption exerciseAcquired | +2,217 | $0.00 | $0 | 8,488.14 | Direct | |
| Feb 6, 2026 | Common Stock | FTax withholdingDisposed | −1,056 | $201.18 | −$212,446.08 | 7,432.14 | Direct | |
| Feb 6, 2026 | Common Stock | MOption exerciseAcquired | +4,683 | $0.00 | $0 | 12,115.14 | Direct | |
| Feb 6, 2026 | Common Stock | FTax withholdingDisposed | −1,412 | $201.18 | −$284,066.16 | 10,703.14 | Direct | |
| Feb 9, 2026 | Common Stock | SSaleDisposed | −2,660 | $199.83 | −$531,547.8 | 8,043.14 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 6, 2026 | Common Stock | MOption exerciseDisposed | −2,217 | $0.00 | $0 | 2,217 | Direct | |
| Feb 6, 2026 | Common Stock | MOption exerciseDisposed | −4,683 | $0.00 | $0 | 9,367 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.